Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8324214 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia
Condition: Lymphoproliferative Disorders
Intervention: Drug: Alemtuzumab (Campath)
2 Completed Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
Conditions: Anemia;   Leukemia, T-Cell;   Lymphocytosis;   Neutropenia;   Thrombocytopenia
Intervention: Drug: cyclosporine

Indicates status has not been verified in more than two years